| Tag | Content |
|---|
EnhancerAtlas ID | HS026-01852 |
Organism | Homo sapiens |
Tissue/cell | CNCC |
Coordinate | chr1:101544200-101546220 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxd3 | MA0041.1 | chr1:101545217-101545229 | AAACAAACAAAC | - | 6.32 | | Foxd3 | MA0041.1 | chr1:101545221-101545233 | AAACAAACAAAC | - | 6.32 | | LMX1B | MA0703.2 | chr1:101544576-101544587 | AATTTAATTAA | + | 6.32 | | Mafb | MA0117.2 | chr1:101544416-101544428 | AGTCAGCATATT | - | 6.52 | | RFX5 | MA0510.2 | chr1:101545160-101545176 | TGTTACCATAGCAATC | + | 6.14 | | RFX5 | MA0510.2 | chr1:101545160-101545176 | TGTTACCATAGCAATC | - | 6.16 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_11746 | chr1:101544101-101546074 | CD20 | | SE_49863 | chr1:101544295-101551176 | RPMI-8402 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I101078 | chr1 | 101544102 | 101546074 |
|
Enhancer Sequence | TCACTGCAAG CTCCGCCTCC CGGGTTCACG CCATTCTCCT GCCTCAGCCT CCCGAGTAGC 60
TGGGACTACA GGCGCCCGCC ACCACGCCTG GCTAATTTTT TGTATTTTTA GTAGAGACGG 120
GGTTTCACCG TGTTAGCCAG GATGGTCTCA ATCTCCTAAC CTCGTGATCC GCCCGCTTCG 180
GCCTCCCAAA GTGTTTTTAT TTGATCTTAT CACAGTAGTC AGCATATTTT GCCTTGTATT 240
ATACTTATAT GTGTACATGT AGTCTTCCCC CAGACTAGCC ATTACTTGAG AGCAAAATTT 300
TAGCCTTATC CGTCTAAATA TCCCCCAAGT GCTTATCTAG TGAATGCCTA ATTGTAATGC 360
CTATTGACTT AAATGGAATT TAATTAAATG GGGTTTGTTA TATTCTGCTA AGACTGTAGT 420
AGATGTAGAC ACAAGTCTGA TTCTTTTCTT ATAACTACCA TTTTCCCCTG TTATGGATAT 480
ATCAAATTAC TTACCACCCT TAACATCTCC TCCAGATTAA TTTGTCTTGT GTAAGCCCCT 540
AGTTGACCAA AGCTGATGGC TGATTAAATT CCCCCAAGGG AACTCAGCCA CACAGCCACA 600
TAGGTTTTTT TTCTTTTTTG GTTGCAAAAA GCAGAAAGGT GCGTATGCAA CAGAGACCAT 660
CTTAAACACG AGAATTATTA GAGTAGCTCA CAGAAAGGTA TCACTGAACA AGCAAGCTTC 720
AGGAGGTTAG AAACCAGGAC AATTCTGAGG ACTCGAGCAT TGAGAACTCA TGAACTCTTT 780
GACCCAGAGC ACCCCAAGGC ACCTCCACTT AAGACTCAAA TTCGAAGGAT CTGTGTAAGC 840
CAGCTTGATT CAATAATCTA ATTCTGTGCT CAGGAAACAG GTGGTTCCTT TTTTTTTTTT 900
TTTAAATCAG AATTTGGAGT TAAGAGGATG CAGGGAGAGT GGTAGACAAA CGGAAACAAG 960
TGTTACCATA GCAATCTATT AGAGGGCAAA CTAAGCCACC AGGAGTCTCT CAAGAACAAA 1020
CAAACAAACA AACAAATGTT ATGAATGACT TTTGGCTTAA ATGTCATGTA GACTAAGACT 1080
GGAGGCGCAA TGGAGAAGGA GGGAAAACTG AGAGCTGATA GAAGCAAAAT GAAGGATAGG 1140
AGTGAGCATC CCCTAAGATG GACAAGGTGC CTTCATTTCC TAATGGTTTC TCCTCTTCTT 1200
TTCTTTGAAC CTACCAATGT GTGGTTATTT TCCTTGCAAT ATTGTGTTGT AAGATATCCT 1260
TCCAATTTAG AAACAGAAAG GGTAGTAATT GCCTCATGTT AGAATATTTA GCTATAGAAT 1320
AATAGGAATC AAAATTATTT TAGACATCAA AGAGTATGGA AAATCAAAGA TAATCTGAGG 1380
CAGCAAGACA CAAATCCCAT TTGTCAATTC TGCCATTTGG TGATCATGAT GGTAGTGATT 1440
TGAGATATGT CTAGCTAAGT ACCAAGCACT GTTTTAAGTA TTTACATATA TTGTTCTCTC 1500
AAAAACTCTG ACGTGTAGGT AGAATTATTA GCCTCATTTT ACACATAAGA GAGCTAAAGT 1560
ATACAAAGAA TAAGTAATGG AGCCAGGATT CAAATTTCCT AATTCAACAT CAAAGCCTAA 1620
ATTCCTGAAA GTGCAAGTCT CTCACAAACT TCAGGAATTC CACAGCATAC CAGAAATCTT 1680
AAGTTTTAGG GTGGTTCGAA ACCTTATAAA TCCCTTTGAG TCAAAAATTT CTCTTTTTTT 1740
CCAGATCCTG TTAAACGTCA GTGTTACTAT TTAGCCTTTG ATATCTCCAG TAAAGGCAAC 1800
TTCTTTCTGG ACCCAGAAAT AAAGCTTTAC ATTAGCAGCT TCCATAACAC CAATAACATG 1860
AATGACCATC TACTGAGCAA TTGCAGTGCA CCAGGATTAT GGCTTATGAG CACTTTATGT 1920
TTATTATCTC ACAACTCACT GAGTTAGATA CTCTCCACAA CCCAGTGAGG TAAATACTAT 1980
TACTTCCACA GTATATATTA TTATATAATA AAATGCTTAG 2020
|
